BSE LIMITED (540025) — Latest Corporate Announcements
₹3,312.5
₹-17.70 (-0.53%)
Market Cap
₹1,34,530.26 Cr
P/E Ratio
48.19
52W Range
₹2326.1 – ₹4446.8
Corporate Actions & Regulatory Filings
Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
Advanced Enzyme Technologies Ltd - 540025 - Disclosure Under Regulation 31A Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (As Amended)
BSE Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
Advanced Enzyme Technologies Ltd - 540025 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
Advanced Enzyme Technologies Ltd - 540025 - Corporate Action-Updates on Buy back
Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
Advanced Enzyme Technologies Ltd - 540025 - Closure of Trading Window
Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
Advanced Enzyme Technologies Ltd - 540025 - Disclosure Under Regulation 31A Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (As Amended)
Financial Results (Quarterly & Annual)
| Quarter / Period | Meeting / Outcome Date | Status | Filing Details |
|---|---|---|---|
| Quarter Ended 30-Jun-2026 (Q1 FY27) | 04-Aug-2026 | Declared | To consider and approve the financial results for the period ended Jun 30, 2026 |
| Year Ended 31-Mar-2026 (Q4 FY26) | 07-May-2026 | Declared | To consider and approve the financial results for the period ended March 31, 2026 and dividend |
| Quarter Ended 31-Dec-2025 (Q3 FY26) | 09-Feb-2026 | Declared | To consider and approve the financial results for the quarter and nine months ended December 31, 2025 |
| Quarter Ended 30-Sep-2025 (Q2 FY26) | 11-Nov-2025 | Declared | To consider and approve the financial results for the period ended September 30, 2025 |
| Quarter Ended 30-Jun-2025 (Q1 FY26) | 07-Aug-2025 | Declared | To consider and approve the financial results for the period ended Jun 30, 2025 |
| Year Ended 31-Mar-2025 (Q4 FY25) | 06-May-2025 | Declared | To consider and approve the financial results for the period ended March 31, 2025 and dividend |
| Quarter Ended 31-Dec-2024 (Q3 FY25) | 06-Feb-2025 | Declared | To consider and approve the financial results for the period ended December 31, 2024 |
| Quarter Ended 30-Sep-2024 (Q2 FY25) | 12-Nov-2024 | Declared | To consider and approve the unaudited financial results for the period ended September 30, 2024 |
| Quarter Ended 30-Jun-2024 (Q1 FY25) | 07-Aug-2024 | Declared | To consider and approve the Unaudited Financial results for the period ended Jun 30, 2024 |
| Year Ended 31-Mar-2024 (Q4 FY24) | 08-May-2024 | Declared | To consider and approve the financial results for the period ended March 31, 2024 and dividend |
| Quarter Ended 31-Dec-2023 (Q3 FY24) | 05-Feb-2024 | Declared | To consider and approve the financial results for the period ended December 31, 2023 |
| Quarter Ended 30-Sep-2023 (Q2 FY24) | 10-Nov-2023 | Declared | To consider and approve the financial results for the period ended September 30, 2023 |
Track Related Peer Equities
Related Research Guides & Regulatory Playbooks
Frequently Asked Questions about BSE LIMITED BSE Disclosures
What is the latest BSE announcement by BSE LIMITED?
The latest BSE disclosure by BSE LIMITED (BSE), filed on 2026-10-12T17:28:34, is: "Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares". Bsenexus tracks every official filing for BSE LIMITED with AI-powered summaries on its announcements feed.
When is BSE LIMITED's next board meeting?
No upcoming board meeting is currently tracked for BSE LIMITED. Companies disclose meeting intimations under SEBI LODR, and scheduled dates appear on the Bsenexus Results Calendar.
When does BSE LIMITED declare quarterly results?
Under SEBI (LODR) Regulation 33, listed companies submit quarterly unaudited results within 45 days of the quarter ending, and annual audited figures within 60 days. BSE LIMITED's recent results history is tabulated above. Track scheduled board meetings on the Bsenexus Results Calendar.